# BIOGEN INC. (BIIB) FY2024 Annual Balance Sheet

- Company: BIOGEN INC. (BIIB)
- Period: As of 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-12, accession number 0000875045-25-000009
- Page: https://plicit.ai/financials/biib/fy2024-annual-balance-sheet
- Chart image: https://plicit.ai/charts/biib-fy2024-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 28,049,300,000 US dollars
- **Current assets**: 7,456,800,000 US dollars
- **Non-current assets**: 20,592,500,000 US dollars
- **Liabilities**: 11,333,300,000 US dollars
- **Current liabilities**: 5,528,800,000 US dollars
- **Non-current liabilities**: 5,804,500,000 US dollars
- **Equity**: 16,716,000,000 US dollars
- **Inventory**: 2,460,500,000 US dollars
- **Cash and cash equivalents**: 2,375,000,000 US dollars
- **Accounts receivable, net of allowance for doubtful accounts of $2.2 and $2.4, respectively**: 1,404,800,000 US dollars
- **Other current assets**: 752,500,000 US dollars
- **Due from anti-CD20 therapeutic programs**: 464,000,000 US dollars
- **Intangible assets, net**: 9,691,200,000 US dollars
- **Goodwill**: 6,478,900,000 US dollars
- **Property, plant and equipment, net**: 3,181,300,000 US dollars
- **Investments and other assets**: 560,500,000 US dollars
- **Operating lease assets**: 356,400,000 US dollars
- **Deferred tax asset**: 324,200,000 US dollars
- **Accrued expense and other**: 2,807,700,000 US dollars
- **Current portion of notes payable and term loan**: 1,748,600,000 US dollars
- **Taxes payable**: 548,300,000 US dollars
- **Accounts payable**: 424,200,000 US dollars
- **Notes payable and term loan**: 4,547,200,000 US dollars
- **Other long-term liabilities**: 732,300,000 US dollars
- **Long-term operating lease liabilities**: 334,500,000 US dollars
- **Deferred tax liability**: 190,500,000 US dollars
- **Retained earnings**: 19,259,800,000 US dollars
- **Additional paid-in capital**: 569,400,000 US dollars
- **Common stock, par value $0.0005 per share**: 100,000 US dollars
- **Preferred stock, par value $0.001 per share**: 0 US dollars
- **Treasury stock, at cost; 23.8 million and 23.8 million shares, respectively**: negative 2,977,100,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 136,200,000 US dollars
- **Gross equity (calculated)**: 19,829,300,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.